Amlodipine Market

Amlodipine, a calcium antagonist, can be used to treat various types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina pectoris (alone or in combination with other drugs).This product has certain protective effect on kidney.The preparation includes amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, levoamlodipine maleic acid tablets, etc.

Amlodipine Market contains market size and forecasts of Amlodipine in global, including the following market information:

Global Amlodipine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Amlodipine Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Amlodipine companies in 2021 (%)

The global Amlodipine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Amlodipine include Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health, Jamp Pharma and Accel Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Amlodipine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Amlodipine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Amlodipine Market Segment Percentages, by Type, 2021 (%)

by Product

Amlodipine Benzene Sulfonate Tablet

Amlodipine Mesylate Tablet

Levoamlodipine Maleic Acid Tablet

by Form

Tablets

Capsule

Global Amlodipine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Amlodipine Market Segment Percentages, by Application, 2021 (%)

High Blood Pressure

Angina Pectoris

Other

Global Amlodipine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Amlodipine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Amlodipine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Amlodipine revenues share in global market, 2021 (%)

Key companies Amlodipine sales in global market, 2017-2022 (Estimated), (KG)

Key companies Amlodipine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis

Pfizer

Lek

TEVA

Macleods Pharmaceuticals

Caraco Pharmaceutical

Sanis Health

Jamp Pharma

Accel Pharma

Jubilant Generics

Angita Pharma

Florida DOH Central Pharmacy

Shanghai Disainuo Biopharmaceutical

Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical

Beijing Wansheng Pharmaceutical

Beijing Honglin Pharmaceutical

Beijing Maidihai Pharmaceutical

China Resources Saike Pharmaceutical

Beijing Jiulong Pharmaceutical

Tiannian Pharmaceutical

Chengdu Diao Pharmaceutical Group

Yangtze Pharmaceutical

Kunming Sino Pharmaceutical

Wuhan Dongxin Pharmaceutical Technology

Jiangsu Wangao Pharmaceutical

Jiangsu Lianhuan Pharmaceutical

Jiangsu Huanghe Pharmaceutical

Zhejiang Jingxin Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

Hunan Qianjinxieli Pharmaceutical